| Tip : |
časopis |
| Internet povezava : |
http://www.currenttherapeuticres.com/article/S0011-393X(15)00016-8/abstract |
|
| Raziskovalne skupine : |
San Francisco - Theravance Biopharma |
| Avtor : |
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. |
| Naslov : |
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. |
| Référence : |
Current Ther Res ; 77: 105-110. 2015 |
|
| Raven dokazov : |
|
| Fizikalna stabilnost : |
|
| Kemična stabilnost : |
|
| Druge metode : |
|
| Komentarji : |
| Razgradni produkti identificirani in kvantificirani |
|
Seznami
 Telavancin hydrochloride
|
 |
 |
 |
 |
15 mg/ml |
2-8°C |
 |
| 7 |
 |
|
|
|
|
|
15 mg/ml |
20-25°C |
 |
| 12 |
 |
|
|
|
|
 |
15 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
 |
|
0.6 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
|
 |
0.6 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
| 7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
| 12 |
|
|
|
|
|
